06:52 AM EDT, 08/01/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q2 adjusted earnings Thursday of $11.56 per diluted share, up from $10.24 a year earlier.
Analysts polled by Capital IQ expected $10.62.
Revenue for the quarter ended June 30 was $3.55 billion compared with $3.16 billion a year earlier.
Analysts surveyed by Capital IQ expected $3.39 billion.
Price: 1,105.77, Change: +26.58, Percent Change: +2.46